MiR-202 suppresses hepatocellular carcinoma progression via down-regulating BCL2 expression.

In conclusion, miR-202 serves as a tumor suppressor in HCC progression by downregulating BCL2 expression, indicating miR-202 might be as a potential target for HCC. PMID: 32272979 [PubMed - as supplied by publisher]
Source: Oncology Research - Category: Cancer & Oncology Tags: Oncol Res Source Type: research